Malaria vaccine shows over 50% efficacy in adults following controlled human malaria infection, supporting further trials in children.

Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments. Using organ-on-a-chip ...

A novel way to prevent the spread of malaria – a potentially life-threatening disease transmitted through bites from mosquitoes infected by a parasite – could soon be realized, thanks to scientists at ...

Malaria, particularly in its severe forms, remains a global health and economic burden. Researchers at EMBL Barcelona, the University of Texas, the University of Copenhagen, and the Scripps Research ...

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, ...

Despite progress toward controlling malaria, it remains a leading cause of morbidity and mortality, particularly in Africa, where 95% of malaria deaths occur according to the World Health Organization ...

Please provide your email address to receive an email when new articles are posted on . There were 282 million malaria cases reported globally in 2024. WHO’s 2025 malaria report links antimalarial ...

A phase 3 trial of Novartis’ next-generation malaria treatment has met its primary endpoint, positioning the drugmaker to seek approval of a therapy with the potential to kill drug-resistant parasites ...

Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five. In a new ...